This website is for UK Healthcare Professionals only

Click the button above to connect with us and make an appointment with a RINVOQ® product specialist.

UC, ulcerative colitis.

1. RINVOQ® Summary of Product Characteristics.

UK-RNQG-220015. Date of preparation: July 2022

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. 
Adverse events should also be reported to AbbVie on GBPV@abbvie.com